Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Dihydroxyphenylalanine and Melatonin

Research Papers that Mention the Interaction

Melatonin treatment significantly reduced the mRNA expression of catecholamine synthases, including the rate-limiting enzyme tyrosine hydroxylase (Th), 3,4-dihydroxyphenylalanine decarboxylase and dopamine-β-hydroxylase expressed in PC12 cells.
The Journal of Steroid Biochemistry and Molecular Biology  •  2017  |  View Paper
When L‐DOPA in small doses (5–8 mg/kg) failed to affect MPTP‐induced akinesia or catalepsy, co‐administration of melatonin with L‐DOPA attenuated these behaviors.
Journal of pineal research  •  2015  |  View Paper
Melatonin treatment significantly attenuated both the l‐DOPA and MPTP‐induced increases in the levels of striatal 6‐OHDA, and protected against striatal DA depletion caused by the neurotoxin.
Journal of pineal research  •  2009  |  View Paper
It is evident that 5-HTP and L-DOPA given at the interval of 8h, as well as melatonin , are potent inhibitors of gonadal development, and the gonado stimulatory effect of the 12-h temporal relationship of the neurotransmitter precursors is masked by the inhibitory effect of melatonin.
Domestic animal endocrinology  •  2009  |  View Paper
Co‐infusion of N‐acetylcysteine (100 μm) or melatonin (50 μm) increased l‐DOPA (up to 151‐ and 246‐fold, respectively) and decreased l‐DOPA‐SQ (by about 53% and 87%, respectively) dialysate concentrations.
These findings demonstrate that endogenous melatonin protects exogenous l‐DOPA from autoxidation in the extracellular compartment of the striatum of freely moving rats; moreover, systemic co‐administration of melatonin with l‐DOPA markedly increases striatal l‐DOPA bioavailability in control as well as in melatonin‐depleted rats.
Journal of pineal research  •  2006  |  View Paper
In addition to β‐adrenergic receptor agonists, L‐dopa and dopamine have been also shown to activate the production of melatonin and its synthesizing enzyme, serotonin N‐acetyltransferase.
Journal of pineal research  •  1984  |  View Paper